Bacterial sepsis in patients with visceral leishmaniasis in Northwest Ethiopia

BioMed Research International

Volumn 2014, Issue , 2014, Pages

  Endris, Mengistu ^a   Takele, Yegnasew ^a   Woldeyohannes, Desalegn ^a,b   Tiruneh, Moges ^a   Mohammed, Rezika ^a   Moges, Feleke ^a   Lynen, Lutgarde ^c   Jacobs, Jan ^c   Van Griensven, Johan ^c   Diro, Ermias ^a,c  

^a UNIVERSITY OF GONDAR   (Ethiopia)

^b ADDIS ABABA SCIENCE AND TECHNOLOGY UNIVERSITY   (Ethiopia)

^c INSTITUTE OF TROPICAL MEDICINE   (Belgium)

Author keywords

[No Author keywords available]

Indexed keywords

AMPICILLIN; CEFOXITIN; CEFTRIAXONE; CHLORAMPHENICOL; CIPROFLOXACIN; ERYTHROMYCIN; GENTAMICIN; METICILLIN; NORFLOXACIN; SULFAMETHOXAZOLE; TETRACYCLINE; VANCOMYCIN;

ADULT; ANTIBIOTIC RESISTANCE; ANTIBIOTIC SENSITIVITY; ARTICLE; BACTERIAL INFECTION; BACTERIAL SEPSIS; BACTERIUM CULTURE; BACTERIUM ISOLATE; BLOOD CULTURE; CROSS-SECTIONAL STUDY; DISEASE ASSOCIATION; ETHIOPIA; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; METHICILLIN RESISTANT STAPHYLOCOCCUS AUREUS; PREVALENCE; SEPSIS; STAPHYLOCOCCUS AUREUS; VISCERAL LEISHMANIASIS; AGE DISTRIBUTION; BACTEREMIA; CLINICAL TRIAL; COMORBIDITY; DEVELOPING COUNTRY; ENDEMIC DISEASE; EPIDEMIOLOGY; LEISHMANIASIS, VISCERAL; NEGLECTED DISEASES; RISK ASSESSMENT; SEX RATIO; STAPHYLOCOCCAL INFECTIONS; STATISTICS AND NUMERICAL DATA; YOUNG ADULT;

ADULT; AGE DISTRIBUTION; BACTEREMIA; COMORBIDITY; CROSS-SECTIONAL STUDIES; DEVELOPING COUNTRIES; ENDEMIC DISEASES; ETHIOPIA; FEMALE; HUMANS; LEISHMANIASIS, VISCERAL; MALE; NEGLECTED DISEASES; PREVALENCE; RISK ASSESSMENT; SEX DISTRIBUTION; STAPHYLOCOCCAL INFECTIONS; YOUNG ADULT;

EID: 84901780716     PISSN: 23146133     EISSN: 23146141     Source Type: Journal    
DOI: 10.1155/2014/361058     Document Type: Article

References (30)

1. van Griensven J., Diro E., Visceral Leishmaniasis. Infectious Disease Clinics of North America 2012 26 309 322
2. Alvar J., Velez I. D., Bern C., Herrero M., Desjeux P., Cano J., Jannin J., den Boer M., Leishmaniasis worldwide and global estimates of its incidence. PLoS ONE 2012 7 e35671
3. Chappuis F., Sundar S., Hailu A., Ghalib H., Rijal S., Peeling R. W., Alvar J., Boelaert M., Visceral leishmaniasis: what are the needs for diagnosis, treatment and control? Nature Reviews Microbiology 2007 5 11 873 882 2-s2.0-35348871028 10.1038/nrmicro1748
4. Hurissa Z., Gebre-Silassie S., Hailu W., Tefera T., Lalloo D. G., Cuevas L. E., Hailu A., Clinical characteristics and treatment outcome of patients with visceral leishmaniasis and HIV co-infection in northwest Ethiopia. Tropical Medicine and International Health 2010 15 7 848 855 2-s2.0-77953184307 10.1111/j.1365-3156.2010.02550.x
5. Mengistu G., Ayele B., Visceral Leishmaniasis and HIV co-infection in patients admitted to Gondar university hospital, northwest Ethiopia. Ethiopian Journal of Health Development 2007 21 53 60
6. Piscopo T., Mallia Azzopardi C., Leishmaniasis. Postgraduate Medical Journal 2007 83 976 649 657 2-s2.0-33947733331 (Pubitemid 44786872)
7. Barati M., Sharifi I., Daie Parizi M., Fasihi Harandi M., Bacterial infections in children with visceral leishmaniasis: observations made in Kerman province, southern Iran, between 1997 and 2007. Annals of Tropical Medicine and Parasitology 2008 102 7 635 641 2-s2.0-55049122779 10.1179/136485908X311858
8. Pearson R., Queiroz S., Jeronimo S., Mandell G., Bennett J., Dolin R., Leishmania species: visceral (kala-azar), cutaneous, and mucosal leishmaniasis. Principles and Practice of Infectious Diseases 2000 1 5th Philadelphia, Pa, USA Churchill Livingstone 2831 2841
9. Magill A., Strickland G., Visceral leishmaniasis (kala-azar). Hunter's Tropical Medicine and Emerging Infectious Diseases 2000 1 8th Philadelphia, Pa, USA W.B. Saunders 670 679
10. Rocha N. A., Silva Júnior G. B., Oliveira M. J. C., Abreu K. L. S., Franco L. F. L. G., Silva M. P., Garcia A. V. V., Daher E. F., Visceral leishmaniasis in children: a cohort of 120 patients in a metropolitan city of Brazil. Turkish Journal of Pediatrics 2011 53 2 154 160 2-s2.0-80052061388
11. Petrela R., Kuneshka L., Foto E., Zavalani F., Gradoni L., Pediatric visceral leishmaniasis in Albania: a retrospective analysis of 1,210 consecutive hospitalized patients (1995-2009). PLoS Neglected Tropical Diseases 2010 4 9, article e814 2-s2.0-78149247782 10.1371/journal.pntd.0000814
12. Yifru S., Wasie B., Clinical pattern of viscerla leishmaniasis in paediatric age group University of Gondar Referral Hospital, Northwest Ethiopia. Ethiopian Journal of Health and Biomedical Sciences 2008 1 23 29
13. Tadesse A., Hurissa Z., Clinical and hematological features and treatment outcomes of visceral leishmaniasis patients admitted to Gondar University Hospital. Ethiopian Journal of Health and Biomedical Sciences 2009 2 41 45
14. WHO, World Health Day 2011-Antibiotic Resistance: No Action Today, No Cure Tomorrow 2011 Geneva, Switzerland World Health Organization
15. WHO, Vandepitte J., Verhaegen J., Engbaek K., Rohner P., Piot P., Heuck C., Basic Laboratory Procedures in Clinical Bacteriology 2003 2nd Geneva, Switzerland World Health Organization
16. CLSI, PerFormance Standards For Antimicrobial Susceptibility Testing 2009 27 9th Clinical and Laboratory Standards Institute
17. CLSI, PerFormance Standards for Antimicrobial Susceptibility Testing, Twenty-Third InFormational Supplement 2012 32 Clinical and Laboratory Standards Institute
18. FDRE Ministry of Health, National Training Package for Provider-Initiated HIV Testing and Counseling 2010 1 Addis Ababa, Ethiopia The Federal Democratic Republic of Ethiopia Ministry of Health
19. Bone R., Balk R., Cerra F., Dellinger R., Fein A., Knaus W., Schein R., Sibbald W., Definitions for sepsis and organ failure and guidelines for the use of innovative therapies in sepsis. The ACCP/SCCM Consensus Conference Committee. American College of Chest Physicians/Society of Critical Care Medicine. Chest 1992 101 1644 1655 2-s2.0-77649201783
20. WHO, Worldwide Prevalence of Anaemia 1993-2005 WHO Global Database on Anaemia 2008 Geneva, Switzerland World Health Organization
21. WHO, Physical Status: The Use and Interpretation of Anthropometry 2004 Geneva, Switzerland World Health Organization
22. Andrade T., Carvalho E., Rocha H., Bacterial infections in patients with visceral leishmaniasis. Journal of Infectious Diseases 1990 162 6 1354 1359 2-s2.0-0025252498
23. Lito G., Davachi F., Sulcebe G., Bregu H., Basha M., Pediatric visceral leishmaniasis in Albania. International Journal of Infectious Diseases 2002 6 1 66 68 2-s2.0-0036298336 10.1016/S1201-9712(02)90139-6 (Pubitemid 34716692)
24. Gopalakrishnan S., Kumar S., A study on chronic otitis media active mucosal type with sinusitis as focal sepsis. Otolaryngology Online Journal 2012 2 1 11
25. Berhe N., Hailu A., Abraham Y., Tadesse Y., Breivik K., Abebe Y., Inter-current and nosocomial infections among visceral leishmaniasis patients in Ethiopia: an observational study. Acta Tropica 2001 80 2 87 95 2-s2.0-0035935150 10.1016/S0001-706X(01)00156-5 (Pubitemid 32964764)
26. Kadivar M., Kajbaf T., Karimi A., Alborzi A., Childhood visceral leishmaniasis complicated by bacterial infections. Eastern Mediterranean Health Journal 2000 6 5-6 879 883 2-s2.0-0034261576
27. Wertheim H. F. L., Melles D. C., Vos M. C., van Leeuwen W., van Belkum A., Verbrugh H. A., Nouwen J. L., The role of nasal carriage in Staphylococcus aureus infections. The Lancet Infectious Diseases 2005 5 12 751 762 2-s2.0-28044446133 10.1016/S1473-3099(05)70295-4 (Pubitemid 41688980)
28. Lazzarin A., Esposito R., Almaviva M., Modifications of leucocyte function in visceral leishmaniasis. Bollettino dell'Istituto Sieroterapico Milanese 1981 60 3 222 224 2-s2.0-0019770954 (Pubitemid 12174646)
29. Fernandes D. J., Rocha H., Characteristics of the inflammatory reaction in patients with hepatosplenic forms of schistosomiasis mansoni and kala-azar. Revista do Instituto de Medicina Tropical de Sao Paulo 1967 9 3 129 134 2-s2.0-16744361895
30. Reddy E. A., Shaw A. V., Crump J. A., Community-acquired bloodstream infections in Africa: a systematic review and meta-analysis. The Lancet Infectious Diseases 2010 10 6 417 432 2-s2.0-77952652892 10.1016/S1473-3099(10) 70072-4